Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
11401
11402
11403
11404
11405
11406
11407
11408
11409
11410
11411
11412
11413
11414
11415
11416
11417
11418
11419
11420
11421
11422
11423
11424
11425
11426
11427
11428
11429
11430
11431
11432
11433
11434
11435
11436
11437
11438
11439
11440
11441
11442
11443
11444
11445
11446
11447
11448
11449
11450
11451
11452
11453
11454
11455
11456
11457
11458
11459
11460
11461
11462
11463
11464
11465
11466
11467
11468
11469
11470
11471
11472
11473
11474
11475
11476
11477
11478
11479
11480
11481
11482
11483
11484
11485
11486
11487
11488
11489
11490
11491
11492
11493
11494
11495
11496
11497
11498
11499
11500
11501
11502
11503
11504
11505
11506
11507
11508
11509
11510
11511
11512
11513
11514
11515
11516
11517
11518
11519
11520
11521
11522
11523
11524
11525
11526
11527
11528
11529
11530
11531
11532
11533
11534
11535
11536
11537
11538
11539
11540
11541
11542
11543
11544
11545
11546
11547
11548
11549
11550
11551
11552
11553
11554
11555
11556
11557
11558
11559
11560
11561
11562
11563
11564
11565
11566
11567
11568
11569
11570
11571
11572
11573
11574
11575
11576
11577
11578
11579
11580
11581
11582
11583
11584
11585
11586
11587
11588
11589
11590
11591
11592
11593
11594
11595
11596
11597
11598
11599
11600
| UnnamedSample_HQ_transcript/4411|m.1962 | UnnamedSample_HQ_transcript/4411 | Coverage 0.235 too low. | 2a4788d19d74c9dc468043b654327db4 | 618 | Pfam | PF00069 | Protein kinase domain | 419 | 524 | 6.4E-20 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/4411|m.1962 | UnnamedSample_HQ_transcript/4411 | Coverage 0.235 too low. | 2a4788d19d74c9dc468043b654327db4 | 618 | Pfam | PF00069 | Protein kinase domain | 219 | 370 | 4.1E-41 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/22293|m.7513 | UnnamedSample_HQ_transcript/22293 | Coverage 0.536 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/21688|m.7339 | UnnamedSample_HQ_transcript/21688 | Coverage 0.465 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/27273|m.8784 | UnnamedSample_HQ_transcript/27273 | Coverage 0.500 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/54277|m.14890 | UnnamedSample_HQ_transcript/54277 | Coverage 0.737 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/54361|m.14913 | UnnamedSample_HQ_transcript/54361 | Coverage 0.770 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/21643|m.7323 | UnnamedSample_HQ_transcript/21643 | Coverage 0.539 too low. | 8e4e6f7ccacdfde0642578a73255cf1e | 630 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.3E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/11314|m.4260 | UnnamedSample_HQ_transcript/11314 | Coverage 0.096 too low. | 249484356890f658819c7e1336e8c246 | 382 | Pfam | PF13927 | Immunoglobulin domain | 256 | 318 | 7.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11314|m.4260 | UnnamedSample_HQ_transcript/11314 | Coverage 0.096 too low. | 249484356890f658819c7e1336e8c246 | 382 | Pfam | PF07679 | Immunoglobulin I-set domain | 30 | 110 | 8.9E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/11314|m.4260 | UnnamedSample_HQ_transcript/11314 | Coverage 0.096 too low. | 249484356890f658819c7e1336e8c246 | 382 | Pfam | PF07679 | Immunoglobulin I-set domain | 335 | 371 | 3.9E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/11314|m.4260 | UnnamedSample_HQ_transcript/11314 | Coverage 0.096 too low. | 249484356890f658819c7e1336e8c246 | 382 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 136 | 224 | 1.0E-16 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/80633|m.19819 | UnnamedSample_HQ_transcript/80633 | Coverage 0.498 too low. | 77b673b57b12c6d51fa826ddcb68bca5 | 242 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 14 | 218 | 3.9E-45 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/98008|m.22367 | UnnamedSample_HQ_transcript/98008 | Coverage 0.254 too low. | 77b673b57b12c6d51fa826ddcb68bca5 | 242 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 14 | 218 | 3.9E-45 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/91902|m.21525 | UnnamedSample_HQ_transcript/91902 | Coverage 0.412 too low. | 77b673b57b12c6d51fa826ddcb68bca5 | 242 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 14 | 218 | 3.9E-45 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/99585|m.22575 | UnnamedSample_HQ_transcript/99585 | Coverage 0.922 too low. | 5853a597b8bb5cfe6893e2c381aa1031 | 302 | Pfam | PF03723 | Hemocyanin, ig-like domain | 33 | 287 | 3.1E-79 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/14852|m.5368 | UnnamedSample_HQ_transcript/14852 | Identity 0.922 too low. | 666cc0f1bd9bc5f5b72b30d514a11d04 | 759 | Pfam | PF01044 | Vinculin family | 1 | 757 | 8.9E-283 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/87937|m.20930 | UnnamedSample_HQ_transcript/87937 | Coverage 0.927 too low. | 4beb4a665b220320a250bbf0e09fbe73 | 369 | Pfam | PF04193 | PQ loop repeat | 263 | 318 | 8.0E-18 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/87937|m.20930 | UnnamedSample_HQ_transcript/87937 | Coverage 0.927 too low. | 4beb4a665b220320a250bbf0e09fbe73 | 369 | Pfam | PF04193 | PQ loop repeat | 124 | 176 | 1.8E-15 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/91196|m.21433 | UnnamedSample_HQ_transcript/91196 | Coverage 0.924 too low. | 4beb4a665b220320a250bbf0e09fbe73 | 369 | Pfam | PF04193 | PQ loop repeat | 263 | 318 | 8.0E-18 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/91196|m.21433 | UnnamedSample_HQ_transcript/91196 | Coverage 0.924 too low. | 4beb4a665b220320a250bbf0e09fbe73 | 369 | Pfam | PF04193 | PQ loop repeat | 124 | 176 | 1.8E-15 | T | 22-09-2020 | IPR006603 | PQ-loop repeat |
| UnnamedSample_HQ_transcript/39572|m.11756 | UnnamedSample_HQ_transcript/39572 | Coverage 0.829 too low. | 8bdc1776aab4fd766e32eab7dcd90028 | 580 | Pfam | PF07690 | Major Facilitator Superfamily | 46 | 222 | 1.9E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/39572|m.11756 | UnnamedSample_HQ_transcript/39572 | Coverage 0.829 too low. | 8bdc1776aab4fd766e32eab7dcd90028 | 580 | Pfam | PF07690 | Major Facilitator Superfamily | 394 | 565 | 5.3E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/11521|m.4335 | UnnamedSample_HQ_transcript/11521 | Identity 0.895 too low. | 927549b9c75e7591e230dc40c28de718 | 1167 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 3.6E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/11521|m.4335 | UnnamedSample_HQ_transcript/11521 | Identity 0.895 too low. | 927549b9c75e7591e230dc40c28de718 | 1167 | Pfam | PF02172 | KIX domain | 803 | 848 | 1.5E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/10361|m.3946 | UnnamedSample_HQ_transcript/10361 | Coverage 0.084 too low. | 930a19f6350247c10fe5c43e474961f0 | 1279 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 156 | 240 | 9.8E-6 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/82536|m.20121 | UnnamedSample_HQ_transcript/82536 | Coverage 0.694 too low. | cd9d8c6b9110d9ddfe5e4d512d32416d | 207 | Pfam | PF01061 | ABC-2 type transporter | 4 | 141 | 6.6E-20 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/41322|m.12122 | UnnamedSample_HQ_transcript/41322 | Coverage 0.044 too low. | fd366000769fadb0a20e322333844ac1 | 746 | Pfam | PF00096 | Zinc finger, C2H2 type | 399 | 421 | 1.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/41322|m.12122 | UnnamedSample_HQ_transcript/41322 | Coverage 0.044 too low. | fd366000769fadb0a20e322333844ac1 | 746 | Pfam | PF13894 | C2H2-type zinc finger | 538 | 560 | 8.5E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9126|m.3554 | UnnamedSample_HQ_transcript/9126 | Identity 0.925 too low. | 10b8e09b5dde8e3d3b0cff001d9db1ff | 1160 | Pfam | PF00567 | Tudor domain | 790 | 871 | 7.8E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/9126|m.3554 | UnnamedSample_HQ_transcript/9126 | Identity 0.925 too low. | 10b8e09b5dde8e3d3b0cff001d9db1ff | 1160 | Pfam | PF00567 | Tudor domain | 919 | 1022 | 2.7E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/9126|m.3554 | UnnamedSample_HQ_transcript/9126 | Identity 0.925 too low. | 10b8e09b5dde8e3d3b0cff001d9db1ff | 1160 | Pfam | PF00567 | Tudor domain | 588 | 696 | 1.1E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/9126|m.3554 | UnnamedSample_HQ_transcript/9126 | Identity 0.925 too low. | 10b8e09b5dde8e3d3b0cff001d9db1ff | 1160 | Pfam | PF00567 | Tudor domain | 381 | 491 | 2.6E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/117671|m.24652 | UnnamedSample_HQ_transcript/117671 | Coverage 0.171 too low. | cfb3eeb34caea11c6fccfc7bc8d65905 | 131 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 2 | 118 | 2.6E-16 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/26280|m.8549 | UnnamedSample_HQ_transcript/26280 | Coverage 0.938 too low. | 9ade898383e92f090886c31d32a00130 | 933 | Pfam | PF02347 | Glycine cleavage system P-protein | 447 | 717 | 6.8E-8 | T | 22-09-2020 | IPR020581 | Glycine cleavage system P protein |
| UnnamedSample_HQ_transcript/26280|m.8549 | UnnamedSample_HQ_transcript/26280 | Coverage 0.938 too low. | 9ade898383e92f090886c31d32a00130 | 933 | Pfam | PF02347 | Glycine cleavage system P-protein | 1 | 411 | 2.9E-169 | T | 22-09-2020 | IPR020581 | Glycine cleavage system P protein |
| UnnamedSample_HQ_transcript/95247|m.21991 | UnnamedSample_HQ_transcript/95247 | Coverage 0.965 too low. | 78bb9c875c8fea33c2b22279983bd110 | 396 | Pfam | PF00067 | Cytochrome P450 | 22 | 395 | 2.0E-69 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/349|m.271 | UnnamedSample_HQ_transcript/349 | Coverage 0.877 too low. | 664e830c435ba5dd583eea84de85cfd8 | 2235 | Pfam | PF18296 | MID domain of medPIWI | 1480 | 1756 | 6.8E-71 | T | 22-09-2020 | IPR041285 | MID domain of medPIWI |
| UnnamedSample_HQ_transcript/349|m.271 | UnnamedSample_HQ_transcript/349 | Coverage 0.877 too low. | 664e830c435ba5dd583eea84de85cfd8 | 2235 | Pfam | PF06333 | Mediator complex subunit 13 C-terminal domain | 1794 | 2224 | 2.0E-110 | T | 22-09-2020 | IPR009401 | Mediator complex subunit Med13, C-terminal |
| UnnamedSample_HQ_transcript/46529|m.13262 | UnnamedSample_HQ_transcript/46529 | Identity 0.893 too low. | 504a144b82fd95e41ba5c350389f9daa | 601 | Pfam | PF10541 | Nuclear envelope localisation domain | 552 | 588 | 1.3E-5 | T | 22-09-2020 | IPR012315 | KASH domain |
| UnnamedSample_HQ_transcript/65642|m.17137 | UnnamedSample_HQ_transcript/65642 | Identity 0.932 too low. | 7d9ccdfb07680be7426ec4a5c9701c1c | 320 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 307 | 2.8E-111 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/64909|m.17018 | UnnamedSample_HQ_transcript/64909 | Identity 0.450 too low. | 38f6a6e600705fccd65f816087e23a72 | 501 | Pfam | PF00128 | Alpha amylase, catalytic domain | 1 | 324 | 3.8E-83 | T | 22-09-2020 | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| UnnamedSample_HQ_transcript/95395|m.22012 | UnnamedSample_HQ_transcript/95395 | Coverage 0.967 too low. | 9f5986d764076a97616bc40c7e92a53b | 209 | Pfam | PF05485 | THAP domain | 4 | 81 | 1.6E-16 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/91670|m.21495 | UnnamedSample_HQ_transcript/91670 | Coverage 0.644 too low. | 86d5cea1671cbf0dc108ac477db6c7f8 | 307 | Pfam | PF10294 | Lysine methyltransferase | 102 | 245 | 4.7E-13 | T | 22-09-2020 | IPR019410 | Lysine methyltransferase |
| UnnamedSample_HQ_transcript/96236|m.22129 | UnnamedSample_HQ_transcript/96236 | Coverage 0.614 too low. | 86d5cea1671cbf0dc108ac477db6c7f8 | 307 | Pfam | PF10294 | Lysine methyltransferase | 102 | 245 | 4.7E-13 | T | 22-09-2020 | IPR019410 | Lysine methyltransferase |
| UnnamedSample_HQ_transcript/111416|m.24013 | UnnamedSample_HQ_transcript/111416 | Coverage 0.984 too low. | 1052d212f267ca7ea27451908fc5f550 | 177 | Pfam | PF00151 | Lipase | 2 | 107 | 1.5E-8 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/112104|m.24092 | UnnamedSample_HQ_transcript/112104 | Coverage 0.988 too low. | c74d009f372f87fad6f55e7c8ef50fcc | 243 | Pfam | PF00719 | Inorganic pyrophosphatase | 1 | 183 | 3.8E-55 | T | 22-09-2020 | IPR008162 | Inorganic pyrophosphatase |
| UnnamedSample_HQ_transcript/45254|m.12966 | UnnamedSample_HQ_transcript/45254 | Unmapped. | 4a309dea0422205900bbabb39b4d9d17 | 402 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 9.3E-7 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/44351|m.12782 | UnnamedSample_HQ_transcript/44351 | Coverage 0.744 too low. | cfad8be5bca51c5305a5e84e8eba27b8 | 371 | Pfam | PF00984 | UDP-glucose/GDP-mannose dehydrogenase family, central domain | 213 | 307 | 1.2E-30 | T | 22-09-2020 | IPR014026 | UDP-glucose/GDP-mannose dehydrogenase, dimerisation |
| UnnamedSample_HQ_transcript/44351|m.12782 | UnnamedSample_HQ_transcript/44351 | Coverage 0.744 too low. | cfad8be5bca51c5305a5e84e8eba27b8 | 371 | Pfam | PF03721 | UDP-glucose/GDP-mannose dehydrogenase family, NAD binding domain | 5 | 186 | 6.4E-63 | T | 22-09-2020 | IPR001732 | UDP-glucose/GDP-mannose dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/44351|m.12782 | UnnamedSample_HQ_transcript/44351 | Coverage 0.744 too low. | cfad8be5bca51c5305a5e84e8eba27b8 | 371 | Pfam | PF03720 | UDP-glucose/GDP-mannose dehydrogenase family, UDP binding domain | 332 | 369 | 1.7E-13 | T | 22-09-2020 | IPR014027 | UDP-glucose/GDP-mannose dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/7839|m.3133 | UnnamedSample_HQ_transcript/7839 | Coverage 0.441 too low. | 8b6850d9ad4006ef5b67f317abab7e70 | 715 | Pfam | PF00053 | Laminin EGF domain | 435 | 495 | 1.1E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/7839|m.3133 | UnnamedSample_HQ_transcript/7839 | Coverage 0.441 too low. | 8b6850d9ad4006ef5b67f317abab7e70 | 715 | Pfam | PF00053 | Laminin EGF domain | 378 | 427 | 3.2E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/7839|m.3133 | UnnamedSample_HQ_transcript/7839 | Coverage 0.441 too low. | 8b6850d9ad4006ef5b67f317abab7e70 | 715 | Pfam | PF00053 | Laminin EGF domain | 498 | 540 | 2.2E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/7839|m.3133 | UnnamedSample_HQ_transcript/7839 | Coverage 0.441 too low. | 8b6850d9ad4006ef5b67f317abab7e70 | 715 | Pfam | PF01759 | UNC-6/NTR/C345C module | 603 | 709 | 4.7E-27 | T | 22-09-2020 | IPR018933 | Netrin module, non-TIMP type |
| UnnamedSample_HQ_transcript/7839|m.3133 | UnnamedSample_HQ_transcript/7839 | Coverage 0.441 too low. | 8b6850d9ad4006ef5b67f317abab7e70 | 715 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 56 | 272 | 1.6E-67 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/70012|m.17933 | UnnamedSample_HQ_transcript/70012 | Coverage 0.961 too low. | 83d6dd279d80ffed489a9db83e82e6b5 | 503 | Pfam | PF00226 | DnaJ domain | 439 | 494 | 2.1E-11 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/70012|m.17933 | UnnamedSample_HQ_transcript/70012 | Coverage 0.961 too low. | 83d6dd279d80ffed489a9db83e82e6b5 | 503 | Pfam | PF00012 | Hsp70 protein | 3 | 426 | 6.5E-123 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/3264|m.1549 | UnnamedSample_HQ_transcript/3264 | Identity 0.557 too low. | 7a4b43e69346876ad0206a5b25f1e4e9 | 1291 | Pfam | PF00780 | CNH domain | 977 | 1254 | 1.2E-61 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/3264|m.1549 | UnnamedSample_HQ_transcript/3264 | Identity 0.557 too low. | 7a4b43e69346876ad0206a5b25f1e4e9 | 1291 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 1.0E-60 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/60543|m.16167 | UnnamedSample_HQ_transcript/60543 | Coverage 0.479 too low. | b1e9d45354d98e155698fa7b8f992e86 | 530 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 37 | 508 | 2.2E-94 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/45930|m.13124 | UnnamedSample_HQ_transcript/45930 | Unmapped. | 1bffe0754db61ae5766a7eb8da0f131a | 288 | Pfam | PF04715 | Anthranilate synthase component I, N terminal region | 22 | 195 | 2.0E-14 | T | 22-09-2020 | IPR006805 | Anthranilate synthase component I, N-terminal |
| UnnamedSample_HQ_transcript/3236|m.1536 | UnnamedSample_HQ_transcript/3236 | Coverage 0.776 too low. | ab821b0f1e40093c04a7392686eeb807 | 511 | Pfam | PF09128 | Regulator of G protein signalling-like domain | 370 | 502 | 8.0E-43 | T | 22-09-2020 | IPR015212 | Regulator of G protein signalling-like domain |
| UnnamedSample_HQ_transcript/49307|m.13872 | UnnamedSample_HQ_transcript/49307 | Coverage 0.135 too low. | 45e9a441f2332ec5e6a57f6bcb923cbd | 678 | Pfam | PF00916 | Sulfate permease family | 112 | 498 | 4.0E-88 | T | 22-09-2020 | IPR011547 | SLC26A/SulP transporter domain |
| UnnamedSample_HQ_transcript/49307|m.13872 | UnnamedSample_HQ_transcript/49307 | Coverage 0.135 too low. | 45e9a441f2332ec5e6a57f6bcb923cbd | 678 | Pfam | PF01740 | STAS domain | 539 | 628 | 6.2E-6 | T | 22-09-2020 | IPR002645 | STAS domain |
| UnnamedSample_HQ_transcript/29583|m.9376 | UnnamedSample_HQ_transcript/29583 | Coverage 0.112 too low. | 35bd49b7d0511c5868a3d7446828f663 | 382 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 274 | 359 | 2.3E-14 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/94734|m.21913 | UnnamedSample_HQ_transcript/94734 | Coverage 0.776 too low. | d68aae7be6990d9ccc07dbf38fb2d755 | 362 | Pfam | PF12832 | MFS_1 like family | 10 | 361 | 3.1E-29 | T | 22-09-2020 | IPR024989 | Major facilitator superfamily associated domain |
| UnnamedSample_HQ_transcript/28299|m.9042 | UnnamedSample_HQ_transcript/28299 | Identity 0.938 too low. | 45a6d6e5e463f5b9b43beee37074759e | 338 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.9E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/21576|m.7302 | UnnamedSample_HQ_transcript/21576 | Coverage 0.535 too low. | 6046afc539d8a242ea06daac76230de6 | 543 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 531 | 4.0E-226 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/54390|m.14918 | UnnamedSample_HQ_transcript/54390 | Coverage 0.810 too low. | 6046afc539d8a242ea06daac76230de6 | 543 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 531 | 4.0E-226 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/112300|m.24115 | UnnamedSample_HQ_transcript/112300 | Coverage 0.986 too low. | 7c1cc6a3bdff6de303b275a002542bdd | 230 | Pfam | PF01399 | PCI domain | 16 | 149 | 2.1E-16 | T | 22-09-2020 | IPR000717 | Proteasome component (PCI) domain |
| UnnamedSample_HQ_transcript/70699|m.18050 | UnnamedSample_HQ_transcript/70699 | Coverage 0.896 too low. | 40e38859606288e143e2cab4244229f0 | 564 | Pfam | PF00012 | Hsp70 protein | 10 | 563 | 8.9E-220 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/89009|m.21086 | UnnamedSample_HQ_transcript/89009 | Coverage 0.156 too low. | 38ca6e11c63beebe65de09c3a768fe5c | 293 | Pfam | PF15279 | Sine oculis-binding protein | 158 | 262 | 6.7E-46 | T | 22-09-2020 | IPR026092 | Retinoic acid-induced protein 2/sine oculis-binding protein homologue |
| UnnamedSample_HQ_transcript/89009|m.21086 | UnnamedSample_HQ_transcript/89009 | Coverage 0.156 too low. | 38ca6e11c63beebe65de09c3a768fe5c | 293 | Pfam | PF06467 | MYM-type Zinc finger with FCS sequence motif | 156 | 192 | 4.8E-5 | T | 22-09-2020 | IPR010507 | Zinc finger, MYM-type |
| UnnamedSample_HQ_transcript/14408|m.5238 | UnnamedSample_HQ_transcript/14408 | Coverage 0.222 too low. | 07ef42f1a07d6fef787082fdb92a3c6f | 1054 | Pfam | PF01426 | BAH domain | 904 | 1050 | 1.5E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/10375|m.3951 | UnnamedSample_HQ_transcript/10375 | Coverage 0.288 too low. | 07ef42f1a07d6fef787082fdb92a3c6f | 1054 | Pfam | PF01426 | BAH domain | 904 | 1050 | 1.5E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/11952|m.4483 | UnnamedSample_HQ_transcript/11952 | Coverage 0.265 too low. | 07ef42f1a07d6fef787082fdb92a3c6f | 1054 | Pfam | PF01426 | BAH domain | 904 | 1050 | 1.5E-12 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/43855|m.12681 | UnnamedSample_HQ_transcript/43855 | Coverage 0.887 too low. | 0c54a9fe539611a61d36fefe3b249aec | 691 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 273 | 461 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/43855|m.12681 | UnnamedSample_HQ_transcript/43855 | Coverage 0.887 too low. | 0c54a9fe539611a61d36fefe3b249aec | 691 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 142 | 4.9E-32 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/43855|m.12681 | UnnamedSample_HQ_transcript/43855 | Coverage 0.887 too low. | 0c54a9fe539611a61d36fefe3b249aec | 691 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 143 | 199 | 4.4E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/43855|m.12681 | UnnamedSample_HQ_transcript/43855 | Coverage 0.887 too low. | 0c54a9fe539611a61d36fefe3b249aec | 691 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 638 | 688 | 7.7E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/18460|m.6436 | UnnamedSample_HQ_transcript/18460 | Identity 0.819 too low. | b3f558f3673340fb2d206ddf482ee32f | 227 | Pfam | PF00271 | Helicase conserved C-terminal domain | 56 | 168 | 4.4E-21 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/113144|m.24200 | UnnamedSample_HQ_transcript/113144 | Coverage 0.986 too low. | 28d0af5585830ebdca7bcc8e63257f03 | 118 | Pfam | PF00107 | Zinc-binding dehydrogenase | 1 | 74 | 2.4E-9 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/54977|m.15038 | UnnamedSample_HQ_transcript/54977 | Coverage 0.256 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF03015 | Male sterility protein | 363 | 455 | 8.7E-29 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/54977|m.15038 | UnnamedSample_HQ_transcript/54977 | Coverage 0.256 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF07993 | Male sterility protein | 18 | 286 | 4.5E-69 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/65393|m.17097 | UnnamedSample_HQ_transcript/65393 | Coverage 0.181 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF03015 | Male sterility protein | 363 | 455 | 8.7E-29 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/65393|m.17097 | UnnamedSample_HQ_transcript/65393 | Coverage 0.181 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF07993 | Male sterility protein | 18 | 286 | 4.5E-69 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/60307|m.16120 | UnnamedSample_HQ_transcript/60307 | Coverage 0.204 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF03015 | Male sterility protein | 363 | 455 | 8.7E-29 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/60307|m.16120 | UnnamedSample_HQ_transcript/60307 | Coverage 0.204 too low. | c31d46701c91c4919b2f5f1b55d5fb5d | 514 | Pfam | PF07993 | Male sterility protein | 18 | 286 | 4.5E-69 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/116247|m.24515 | UnnamedSample_HQ_transcript/116247 | Identity 0.922 too low. | 740286af23191bd14ce2d10561f2e481 | 102 | Pfam | PF01251 | Ribosomal protein S7e | 16 | 95 | 4.4E-10 | T | 22-09-2020 | IPR000554 | Ribosomal protein S7e |
| UnnamedSample_HQ_transcript/1559|m.876 | UnnamedSample_HQ_transcript/1559 | Unmapped. | cd35937f6f670eb1ac102e0e600f0bbb | 952 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.0E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/34734|m.10661 | UnnamedSample_HQ_transcript/34734 | Identity 0.838 too low. | 8a0741ab870692056a1b3c352f945d6e | 431 | Pfam | PF00743 | Flavin-binding monooxygenase-like | 7 | 225 | 2.3E-36 | T | 22-09-2020 | IPR020946 | Flavin monooxygenase-like |
| UnnamedSample_HQ_transcript/34734|m.10661 | UnnamedSample_HQ_transcript/34734 | Identity 0.838 too low. | 8a0741ab870692056a1b3c352f945d6e | 431 | Pfam | PF00743 | Flavin-binding monooxygenase-like | 237 | 396 | 3.6E-16 | T | 22-09-2020 | IPR020946 | Flavin monooxygenase-like |
| UnnamedSample_HQ_transcript/10634|m.4036 | UnnamedSample_HQ_transcript/10634 | Coverage 0.934 too low. | a74717a1e0e5d8aeb35b547f033e65e4 | 694 | Pfam | PF00041 | Fibronectin type III domain | 209 | 317 | 9.7E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/10634|m.4036 | UnnamedSample_HQ_transcript/10634 | Coverage 0.934 too low. | a74717a1e0e5d8aeb35b547f033e65e4 | 694 | Pfam | PF07679 | Immunoglobulin I-set domain | 105 | 202 | 6.6E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/10634|m.4036 | UnnamedSample_HQ_transcript/10634 | Coverage 0.934 too low. | a74717a1e0e5d8aeb35b547f033e65e4 | 694 | Pfam | PF13927 | Immunoglobulin domain | 9 | 86 | 9.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/110158|m.23858 | UnnamedSample_HQ_transcript/110158 | Coverage 0.300 too low. | 4ca2fc6bcc4f54d3ef8b2571427d28af | 149 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 44 | 141 | 1.9E-30 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/91108|m.21422 | UnnamedSample_HQ_transcript/91108 | Coverage 0.519 too low. | 4ca2fc6bcc4f54d3ef8b2571427d28af | 149 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 44 | 141 | 1.9E-30 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/104140|m.23124 | UnnamedSample_HQ_transcript/104140 | Coverage 0.167 too low. | 4ca2fc6bcc4f54d3ef8b2571427d28af | 149 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 44 | 141 | 1.9E-30 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 737 | 822 | 8.2E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 79 | 163 | 4.5E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 547 | 633 | 1.2E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 924 | 1013 | 4.7E-17 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 830 | 916 | 8.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 174 | 259 | 2.1E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 264 | 349 | 8.7E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11663|m.4378 | UnnamedSample_HQ_transcript/11663 | Coverage 0.764 too low. | d46abb5976a847ef21212edfc78927ec | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 363 | 444 | 1.6E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/81702|m.19982 | UnnamedSample_HQ_transcript/81702 | Coverage 0.860 too low. | 4a6fb94f3a8ffdd73ac46740519de695 | 377 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.1E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/29358|m.9315 | UnnamedSample_HQ_transcript/29358 | Coverage 0.988 too low. | c956cfb77d86397ee4dc0ed53fbed08e | 440 | Pfam | PF00202 | Aminotransferase class-III | 33 | 437 | 8.6E-80 | T | 22-09-2020 | IPR005814 | Aminotransferase class-III |
| UnnamedSample_HQ_transcript/32434|m.10063 | UnnamedSample_HQ_transcript/32434 | Coverage 0.988 too low. | c956cfb77d86397ee4dc0ed53fbed08e | 440 | Pfam | PF00202 | Aminotransferase class-III | 33 | 437 | 8.6E-80 | T | 22-09-2020 | IPR005814 | Aminotransferase class-III |
| UnnamedSample_HQ_transcript/4192|m.1881 | UnnamedSample_HQ_transcript/4192 | Coverage 0.735 too low. | ab3a5cb8711b7c047b1828af66941450 | 176 | Pfam | PF13975 | gag-polyprotein putative aspartyl protease | 50 | 134 | 1.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/26152|m.8516 | UnnamedSample_HQ_transcript/26152 | Coverage 0.346 too low. | 97f70db616c3b863bfc452e7032ea830 | 815 | Pfam | PF07686 | Immunoglobulin V-set domain | 48 | 148 | 1.9E-6 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/26152|m.8516 | UnnamedSample_HQ_transcript/26152 | Coverage 0.346 too low. | 97f70db616c3b863bfc452e7032ea830 | 815 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 232 | 302 | 8.9E-6 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/26152|m.8516 | UnnamedSample_HQ_transcript/26152 | Coverage 0.346 too low. | 97f70db616c3b863bfc452e7032ea830 | 815 | Pfam | PF07679 | Immunoglobulin I-set domain | 328 | 412 | 6.4E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 8.2E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 8.2E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.6E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 3.1E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.8E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/5270|m.2286 | UnnamedSample_HQ_transcript/5270 | Coverage 0.920 too low. | 31fa2023915274b30bdaaf5d46ec40bc | 867 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.2E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/22065|m.7446 | UnnamedSample_HQ_transcript/22065 | Coverage 0.984 too low. | 04b675606b3f9f595fe5d961e00f49a4 | 844 | Pfam | PF00651 | BTB/POZ domain | 296 | 414 | 4.9E-16 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/22065|m.7446 | UnnamedSample_HQ_transcript/22065 | Coverage 0.984 too low. | 04b675606b3f9f595fe5d961e00f49a4 | 844 | Pfam | PF00651 | BTB/POZ domain | 17 | 116 | 1.5E-10 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/49726|m.13964 | UnnamedSample_HQ_transcript/49726 | Coverage 0.984 too low. | ca91e3fd9b586fe92dced31b35401445 | 726 | Pfam | PF01480 | PWI domain | 43 | 114 | 1.5E-30 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/43489|m.12598 | UnnamedSample_HQ_transcript/43489 | Coverage 0.985 too low. | ca91e3fd9b586fe92dced31b35401445 | 726 | Pfam | PF01480 | PWI domain | 43 | 114 | 1.5E-30 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/92559|m.21606 | UnnamedSample_HQ_transcript/92559 | Coverage 0.287 too low. | 569b9dc1db66f1f6616188eb8309224c | 276 | Pfam | PF07898 | Protein of unknown function (DUF1676) | 30 | 211 | 4.4E-43 | T | 22-09-2020 | IPR012464 | Protein of unknown function DUF1676 |
| UnnamedSample_HQ_transcript/2723|m.1328 | UnnamedSample_HQ_transcript/2723 | Coverage 0.868 too low. | 6953b24b389bd8a806cfea238dc9d0dd | 600 | Pfam | PF12004 | Domain of unknown function (DUF3498) | 505 | 565 | 1.2E-19 | T | 22-09-2020 | IPR021887 | Domain of unknown function DUF3498 |
| UnnamedSample_HQ_transcript/49150|m.13841 | UnnamedSample_HQ_transcript/49150 | Coverage 0.751 too low. | 95116f7f0d86bc8f974aef1d7b67f19e | 618 | Pfam | PF00012 | Hsp70 protein | 1 | 541 | 2.5E-174 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/49150|m.13841 | UnnamedSample_HQ_transcript/49150 | Coverage 0.751 too low. | 95116f7f0d86bc8f974aef1d7b67f19e | 618 | Pfam | PF00226 | DnaJ domain | 554 | 609 | 2.8E-11 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/74385|m.18720 | UnnamedSample_HQ_transcript/74385 | Coverage 0.882 too low. | ecad28f02abaef0754a3303eecb2d872 | 223 | Pfam | PF03770 | Inositol polyphosphate kinase | 183 | 209 | 3.4E-7 | T | 22-09-2020 | IPR005522 | Inositol polyphosphate kinase |
| UnnamedSample_HQ_transcript/95878|m.22069 | UnnamedSample_HQ_transcript/95878 | Identity 0.772 too low. | f5d541251fab55b8f89dba0737616195 | 318 | Pfam | PF00650 | CRAL/TRIO domain | 132 | 284 | 2.0E-36 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/52501|m.14547 | UnnamedSample_HQ_transcript/52501 | Unmapped. | cfd2744d1616fd5f89565ff07d45ffac | 243 | Pfam | PF07992 | Pyridine nucleotide-disulphide oxidoreductase | 5 | 239 | 9.4E-33 | T | 22-09-2020 | IPR023753 | FAD/NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/101379|m.22795 | UnnamedSample_HQ_transcript/101379 | Coverage 0.104 too low. | 82296651ea5cc0b0224485152e910e00 | 180 | Pfam | PF00372 | Hemocyanin, copper containing domain | 5 | 177 | 8.7E-39 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/41442|m.12149 | UnnamedSample_HQ_transcript/41442 | Coverage 0.462 too low. | c9c07e7193b3c326b0c74bb88f7aba08 | 376 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 3.6E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/41442|m.12149 | UnnamedSample_HQ_transcript/41442 | Coverage 0.462 too low. | c9c07e7193b3c326b0c74bb88f7aba08 | 376 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 343 | 3.0E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/3005|m.1443 | UnnamedSample_HQ_transcript/3005 | Coverage 0.225 too low. | 094093e62d0fb4746a9d5837d8beadd3 | 750 | Pfam | PF00400 | WD domain, G-beta repeat | 537 | 564 | 0.11 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/3005|m.1443 | UnnamedSample_HQ_transcript/3005 | Coverage 0.225 too low. | 094093e62d0fb4746a9d5837d8beadd3 | 750 | Pfam | PF00400 | WD domain, G-beta repeat | 638 | 666 | 0.15 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/3005|m.1443 | UnnamedSample_HQ_transcript/3005 | Coverage 0.225 too low. | 094093e62d0fb4746a9d5837d8beadd3 | 750 | Pfam | PF02985 | HEAT repeat | 129 | 152 | 3.0E-4 | T | 22-09-2020 | IPR000357 | HEAT repeat |
| UnnamedSample_HQ_transcript/26434|m.8588 | UnnamedSample_HQ_transcript/26434 | Coverage 0.536 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/26434|m.8588 | UnnamedSample_HQ_transcript/26434 | Coverage 0.536 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/57442|m.15533 | UnnamedSample_HQ_transcript/57442 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/57442|m.15533 | UnnamedSample_HQ_transcript/57442 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/86419|m.20711 | UnnamedSample_HQ_transcript/86419 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/86419|m.20711 | UnnamedSample_HQ_transcript/86419 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/73489|m.18567 | UnnamedSample_HQ_transcript/73489 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/73489|m.18567 | UnnamedSample_HQ_transcript/73489 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/80382|m.19779 | UnnamedSample_HQ_transcript/80382 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/80382|m.19779 | UnnamedSample_HQ_transcript/80382 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/82828|m.20166 | UnnamedSample_HQ_transcript/82828 | Coverage 0.441 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/82828|m.20166 | UnnamedSample_HQ_transcript/82828 | Coverage 0.441 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/88611|m.21033 | UnnamedSample_HQ_transcript/88611 | Coverage 0.298 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/88611|m.21033 | UnnamedSample_HQ_transcript/88611 | Coverage 0.298 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60025|m.16064 | UnnamedSample_HQ_transcript/60025 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60025|m.16064 | UnnamedSample_HQ_transcript/60025 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/72750|m.18435 | UnnamedSample_HQ_transcript/72750 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/72750|m.18435 | UnnamedSample_HQ_transcript/72750 | Unmapped. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/74668|m.18771 | UnnamedSample_HQ_transcript/74668 | Coverage 0.410 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 24 | 92 | 1.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/74668|m.18771 | UnnamedSample_HQ_transcript/74668 | Coverage 0.410 too low. | b2fbd570e15b491b4edb62b69a2914eb | 340 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 115 | 171 | 5.4E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/69219|m.17797 | UnnamedSample_HQ_transcript/69219 | Identity 0.796 too low. | 6e079c259c171916b9582b3658fda6ea | 212 | Pfam | PF00171 | Aldehyde dehydrogenase family | 4 | 203 | 9.7E-78 | T | 22-09-2020 | IPR015590 | Aldehyde dehydrogenase domain |
| UnnamedSample_HQ_transcript/103685|m.23071 | UnnamedSample_HQ_transcript/103685 | Coverage 0.979 too low. | 6e079c259c171916b9582b3658fda6ea | 212 | Pfam | PF00171 | Aldehyde dehydrogenase family | 4 | 203 | 9.7E-78 | T | 22-09-2020 | IPR015590 | Aldehyde dehydrogenase domain |
| UnnamedSample_HQ_transcript/106781|m.23429 | UnnamedSample_HQ_transcript/106781 | Coverage 0.980 too low. | 6e079c259c171916b9582b3658fda6ea | 212 | Pfam | PF00171 | Aldehyde dehydrogenase family | 4 | 203 | 9.7E-78 | T | 22-09-2020 | IPR015590 | Aldehyde dehydrogenase domain |
| UnnamedSample_HQ_transcript/42111|m.12289 | UnnamedSample_HQ_transcript/42111 | Identity 0.906 too low. | 98ddf9d382a65f98a60d37436769e267 | 602 | Pfam | PF01061 | ABC-2 type transporter | 401 | 539 | 1.7E-31 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/42111|m.12289 | UnnamedSample_HQ_transcript/42111 | Identity 0.906 too low. | 98ddf9d382a65f98a60d37436769e267 | 602 | Pfam | PF01061 | ABC-2 type transporter | 292 | 370 | 5.1E-10 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/42111|m.12289 | UnnamedSample_HQ_transcript/42111 | Identity 0.906 too low. | 98ddf9d382a65f98a60d37436769e267 | 602 | Pfam | PF19055 | ABC-2 type transporter | 168 | 240 | 1.3E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/42111|m.12289 | UnnamedSample_HQ_transcript/42111 | Identity 0.906 too low. | 98ddf9d382a65f98a60d37436769e267 | 602 | Pfam | PF00005 | ABC transporter | 1 | 139 | 1.2E-16 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/100045|m.22644 | UnnamedSample_HQ_transcript/100045 | Coverage 0.561 too low. | 825d8243828aaef855f6f9daceb5908f | 128 | Pfam | PF12936 | KRI1-like family C-terminal | 16 | 103 | 2.8E-31 | T | 22-09-2020 | IPR024626 | Kri1-like, C-terminal |
| UnnamedSample_HQ_transcript/98584|m.22443 | UnnamedSample_HQ_transcript/98584 | Coverage 0.815 too low. | 2d243a7369b27c88827dbd991205a010 | 182 | Pfam | PF16676 | Transactivation domain of FOXO protein family | 113 | 149 | 2.4E-9 | T | 22-09-2020 | IPR032067 | FOXO protein, transactivation domain |
| UnnamedSample_HQ_transcript/114412|m.24334 | UnnamedSample_HQ_transcript/114412 | Coverage 0.968 too low. | 52de2fe01a1a32594b82683987f8fb9d | 123 | Pfam | PF00992 | Troponin | 28 | 104 | 5.1E-11 | T | 22-09-2020 | IPR001978 | Troponin |
| UnnamedSample_HQ_transcript/18142|m.6350 | UnnamedSample_HQ_transcript/18142 | Coverage 0.855 too low. | 88c0890d45d84fc5202738585c37d023 | 755 | Pfam | PF00096 | Zinc finger, C2H2 type | 613 | 635 | 1.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/83670|m.20290 | UnnamedSample_HQ_transcript/83670 | Coverage 0.306 too low. | 115074a83400747db5d5ebdf910300ed | 245 | Pfam | PF02338 | OTU-like cysteine protease | 27 | 94 | 3.2E-13 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/101211|m.22779 | UnnamedSample_HQ_transcript/101211 | Coverage 0.106 too low. | 115074a83400747db5d5ebdf910300ed | 245 | Pfam | PF02338 | OTU-like cysteine protease | 27 | 94 | 3.2E-13 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/89275|m.21126 | UnnamedSample_HQ_transcript/89275 | Coverage 0.260 too low. | 115074a83400747db5d5ebdf910300ed | 245 | Pfam | PF02338 | OTU-like cysteine protease | 27 | 94 | 3.2E-13 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/94706|m.21910 | UnnamedSample_HQ_transcript/94706 | Coverage 0.204 too low. | 115074a83400747db5d5ebdf910300ed | 245 | Pfam | PF02338 | OTU-like cysteine protease | 27 | 94 | 3.2E-13 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/89065|m.21093 | UnnamedSample_HQ_transcript/89065 | Identity 0.857 too low. | 9611dc8fc8e95a86c733f7aa9ac78bc4 | 160 | Pfam | PF08880 | QLQ | 83 | 117 | 6.7E-11 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/69394|m.17830 | UnnamedSample_HQ_transcript/69394 | Coverage 0.806 too low. | 691f8c2aa98c0de390134c193ea2f52d | 462 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 4.0E-13 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/69394|m.17830 | UnnamedSample_HQ_transcript/69394 | Coverage 0.806 too low. | 691f8c2aa98c0de390134c193ea2f52d | 462 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 3.6E-27 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/69394|m.17830 | UnnamedSample_HQ_transcript/69394 | Coverage 0.806 too low. | 691f8c2aa98c0de390134c193ea2f52d | 462 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 1.2E-20 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/117761|m.24661 | UnnamedSample_HQ_transcript/117761 | Coverage 0.221 too low. | cf337b9fc0380c73a7c76d1c96770fca | 189 | Pfam | PF00849 | RNA pseudouridylate synthase | 22 | 170 | 8.2E-31 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/32713|m.10141 | UnnamedSample_HQ_transcript/32713 | Coverage 0.700 too low. | 010b80a7ebfea002761dae128b0b9974 | 744 | Pfam | PF00595 | PDZ domain | 216 | 298 | 1.2E-19 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/32713|m.10141 | UnnamedSample_HQ_transcript/32713 | Coverage 0.700 too low. | 010b80a7ebfea002761dae128b0b9974 | 744 | Pfam | PF00595 | PDZ domain | 318 | 405 | 2.8E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/32713|m.10141 | UnnamedSample_HQ_transcript/32713 | Coverage 0.700 too low. | 010b80a7ebfea002761dae128b0b9974 | 744 | Pfam | PF00595 | PDZ domain | 467 | 544 | 5.9E-19 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/32713|m.10141 | UnnamedSample_HQ_transcript/32713 | Coverage 0.700 too low. | 010b80a7ebfea002761dae128b0b9974 | 744 | Pfam | PF07653 | Variant SH3 domain | 580 | 640 | 2.8E-6 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/32713|m.10141 | UnnamedSample_HQ_transcript/32713 | Coverage 0.700 too low. | 010b80a7ebfea002761dae128b0b9974 | 744 | Pfam | PF09058 | L27_1 | 2 | 62 | 1.8E-30 | T | 22-09-2020 | IPR015143 | L27-1 |
| UnnamedSample_HQ_transcript/60327|m.16127 | UnnamedSample_HQ_transcript/60327 | Coverage 0.676 too low. | f0d49504eb9394f958815361e0bbaadd | 125 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 84 | 113 | 0.012 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/60327|m.16127 | UnnamedSample_HQ_transcript/60327 | Coverage 0.676 too low. | f0d49504eb9394f958815361e0bbaadd | 125 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 22 | 68 | 0.0044 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/48120|m.13611 | UnnamedSample_HQ_transcript/48120 | Coverage 0.833 too low. | f4776070eb9ed5fb6efa11ab8202ccaa | 413 | Pfam | PF00135 | Carboxylesterase family | 5 | 378 | 2.6E-70 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/56305|m.15302 | UnnamedSample_HQ_transcript/56305 | Coverage 0.981 too low. | 0357a2307ee1abbac2b166cbfe04d763 | 519 | Pfam | PF07776 | Zinc-finger associated domain (zf-AD) | 25 | 99 | 1.8E-10 | T | 22-09-2020 | IPR012934 | Zinc finger, AD-type |
| UnnamedSample_HQ_transcript/56305|m.15302 | UnnamedSample_HQ_transcript/56305 | Coverage 0.981 too low. | 0357a2307ee1abbac2b166cbfe04d763 | 519 | Pfam | PF00096 | Zinc finger, C2H2 type | 261 | 284 | 1.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/56305|m.15302 | UnnamedSample_HQ_transcript/56305 | Coverage 0.981 too low. | 0357a2307ee1abbac2b166cbfe04d763 | 519 | Pfam | PF00096 | Zinc finger, C2H2 type | 412 | 434 | 7.3E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/56305|m.15302 | UnnamedSample_HQ_transcript/56305 | Coverage 0.981 too low. | 0357a2307ee1abbac2b166cbfe04d763 | 519 | Pfam | PF13912 | C2H2-type zinc finger | 384 | 408 | 3.4E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/94048|m.21809 | UnnamedSample_HQ_transcript/94048 | Unmapped. | 7759272a8d69321396b1e0957bbcc74a | 359 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/80534|m.19807 | UnnamedSample_HQ_transcript/80534 | Unmapped. | 7759272a8d69321396b1e0957bbcc74a | 359 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/85256|m.20535 | UnnamedSample_HQ_transcript/85256 | Unmapped. | 7759272a8d69321396b1e0957bbcc74a | 359 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/89915|m.21242 | UnnamedSample_HQ_transcript/89915 | Unmapped. | 7759272a8d69321396b1e0957bbcc74a | 359 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/97945|m.22356 | UnnamedSample_HQ_transcript/97945 | Unmapped. | 7759272a8d69321396b1e0957bbcc74a | 359 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/84881|m.20477 | UnnamedSample_HQ_transcript/84881 | Coverage 0.175 too low. | d84e8b0b9e74fe02ec306e26622858b1 | 410 | Pfam | PF02799 | Myristoyl-CoA:protein N-myristoyltransferase, C-terminal domain | 287 | 385 | 2.1E-28 | T | 22-09-2020 | IPR022677 | Myristoyl-CoA:protein N-myristoyltransferase, C-terminal |
| UnnamedSample_HQ_transcript/84881|m.20477 | UnnamedSample_HQ_transcript/84881 | Coverage 0.175 too low. | d84e8b0b9e74fe02ec306e26622858b1 | 410 | Pfam | PF01233 | Myristoyl-CoA:protein N-myristoyltransferase, N-terminal domain | 114 | 273 | 1.0E-75 | T | 22-09-2020 | IPR022676 | Myristoyl-CoA:protein N-myristoyltransferase, N-terminal |
| UnnamedSample_HQ_transcript/89409|m.21147 | UnnamedSample_HQ_transcript/89409 | Coverage 0.979 too low. | e7fa44929d8f270390cb165c9af048f6 | 373 | Pfam | PF13907 | Domain of unknown function (DUF4208) | 255 | 344 | 3.6E-24 | T | 22-09-2020 | IPR025260 | Domain of unknown function DUF4208 |
| UnnamedSample_HQ_transcript/9358|m.3631 | UnnamedSample_HQ_transcript/9358 | Coverage 0.164 too low. | f1a4cef6ac7ec14682e8b1aaf2a21bf9 | 1186 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 798 | 919 | 4.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/9358|m.3631 | UnnamedSample_HQ_transcript/9358 | Coverage 0.164 too low. | f1a4cef6ac7ec14682e8b1aaf2a21bf9 | 1186 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 192 | 758 | 8.3E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
